Reaction
Product Closure Issue reporting signals
As of the last recalculation, Product Closure Issue appears in 538 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ALTEPLASE (PRR 183.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alteplase | 63 | 183.7 | 184.5 |
| Testosterone Cypionate | 15 | 66.8 | 66.9 |
| Lifitegrast | 5 | 11.9 | 11.9 |
| Guselkumab | 6 | 6.6 | 6.6 |